Karoline Horisberger

Cetuximab in Combination With Capecitabine, Irinotecan, and Radiotherapy for Patients With Locally Advanced Rectal Cancer: Results of a Phase II MARGIT Trial

Karoline Horisberger, Anne Treschl, Sabine Mai et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 108 citations

Radiation Therapy, Gastrointestinal Oncology, Medicine +6

A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer

Frank Willeke, Karoline Horisberger, Uta Kraus-Tiefenbacher et al. · British Journal of Cancer · 2007 · 103 citations · Full text

Artificial intelligence for detection of microsatellite instability in colorectal cancer—a multicentric analysis of a pre-screening tool for clinical application

Amelie Echle, Narmin Ghaffari Laleh, Philip Quirke et al. · ESMO Open · 2022 · 101 citations · Full text

Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer

Ralf‐Dieter Hofheinz, Karoline Horisberger, Christoph M. Woernle et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 94 citations

Surgical Oncology, Radiation Therapy, Neoadjuvant Therapy +10

Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database

Mev Dominguez–Valentin, Saskia Haupt, Toni T. Seppälä et al. · EClinicalMedicine · 2023 · 91 citations · Full text